Print friendly version
Other Names for this Disease
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
Anti-epileptic drugs are usually not effective in controlling the seizures associated with Rasmussen encephalitis. Recent studies have shown some success with treatments that suppress or modulate the immune system, in particular those that use corticosteroids, intravenous immunoglobulin, or tacrolimus. Surgery to control seizures may be performed in later stages of the disease when neurological deficits stabilize. Surgical procedures, such as functional hemispherectomy (removal of half of the brain) and hemispherotomy (a surgical procedure for hemispheric disconnection), may reduce the frequency of seizures and also improve behavior and cognitive abilities.
Last updated: 3/22/2012
- NINDS Rasmussen's Encephalitis Information Page. National Institute of Neurological Disorders and Stroke (NINDS). December 19, 2011; http://www.ninds.nih.gov/disorders/rasmussen/rasmussen.htm. Accessed 3/22/2012.
Clinical Trials & Research for this Disease
- ClinicalTrials.gov lists trials that are studying or have studied Rasmussen encephalitis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.